WeSearch

STAT+: Eli Lilly to buy three small vaccine developers

5 sources covered this ⚠ Left-only compare →
All three outlets report on the acquisition, but they differ in emphasis. The Globe and Mail highlights Lilly's strategic shift into new therapeutic areas, while STAT News focuses on the potential impact of the acquisition on the vaccine…
Andrew Joseph· ·1 min read · 0 reactions · 0 comments · 19 views
STAT+: Eli Lilly to buy three small vaccine developers

Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases and giving the field a boost.

Original article
STAT News · Andrew Joseph
Read full at STAT News →
Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from STAT News

STAT+: Legend Biotech emerged as a rare market winner
STAT News·5
STAT+: BioNTech and Pfizer tout bispecifics data, and Pazdur sees silver lining at FDA
STAT News·13
STAT+: China competition, ‘destruction’ at FDA gives agency chance to restructure, Rick Pazdur says
STAT News·8
STAT+: As Ebola outbreak grows, Trump administration veers from previous government playbook
STAT News·12
STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
STAT News·12
STAT+: Allogene CEO David Chang stepping down
STAT News·17